Literature DB >> 6232607

Psychiatric features of Huntington's disease: recent approaches and findings.

S E Folstein, M F Folstein.   

Abstract

The psychiatric manifestations of Huntington's Disease (HD) include dementia, irritability and apathy, a major affective syndrome, and hallucinosis. The theoretical and practical utility of chorea as a focus of research interest in HD is questioned, whereas the data reviewed suggest that assessments of cognition, functional capacity and motor impairment are better correlated neuropathologically, and are better indicators of disease severity and progress than chorea. The high incidence of major affective disorders on modified DSM III criteria among HD patients (41 per cent) may be explained either as a manifestation of genetic heterogeneity within the HD phenotype or on the basis of genetic linkage between HD and manic depressive illness (MDI). This is supported by the high coincidence of HD and MDI (20 out of 23) among secondary cases of HD ascertained through probands having both disorders, indicating a strong familial clustering of the association. This implies that a young adult at risk for HD who has had episodes of severe depression has considerably more than 50 per cent likelihood of progressing to manifest HD. Although auditory hallucinations appear occasionally in patients with HD, most do not meet current criteria for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6232607

Source DB:  PubMed          Journal:  Psychiatr Dev        ISSN: 0262-9283


  15 in total

1.  Familial psychiatric presentation of Huntington's disease.

Authors:  S Lovestone; S Hodgson; P Sham; A M Differ; R Levy
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

2.  Huntington disease as a dual diagnosis disorder: data from the National Research Roster for Huntington disease patients and families.

Authors:  Jason C Ehret; Patricia S Day; Ryan Wiegand; Joanne Wojcieszek; R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2006-08-22       Impact factor: 4.492

3.  Huntington disease in Maryland: clinical aspects of racial variation.

Authors:  S E Folstein; G A Chase; W E Wahl; A M McDonnell; M F Folstein
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

Review 4.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

5.  Behavioral Changes in Huntington Disease

Authors:  Jason Brandt
Journal:  Cogn Behav Neurol       Date:  2018-03       Impact factor: 1.600

6.  Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice.

Authors:  Mark Pitzer; Jordan Lueras; Anna Warden; Sydney Weber; Jodi McBride
Journal:  Brain Res       Date:  2015-02-28       Impact factor: 3.252

7.  Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences.

Authors:  M Mercedes Perez-Rodriguez; Erin A Hazlett; Erin L Rich; Luis H Ripoll; Daniel M Weiner; Nicole Spence; Marianne Goodman; Harold W Koenigsberg; Larry J Siever; Antonia S New
Journal:  J Psychiatr Res       Date:  2012-03-29       Impact factor: 4.791

8.  Neuropsychiatric aspects of Huntington's disease.

Authors:  J S Paulsen; R E Ready; J M Hamilton; M S Mega; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

9.  Neuroendocrine Coordination of Mitochondrial Stress Signaling and Proteostasis.

Authors:  Kristen M Berendzen; Jenni Durieux; Li-Wa Shao; Ye Tian; Hyun-Eui Kim; Suzanne Wolff; Ying Liu; Andrew Dillin
Journal:  Cell       Date:  2016-09-08       Impact factor: 41.582

Review 10.  Mania in the medically ill.

Authors:  Monica Arora; Joan Daughton
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.